European Heart Journal-Cardiovascular Pharmacotherapy

European Heart Journal-Cardiovascular Pharmacotherapy 由 Oxford University Press 出版，属中科院医学大类（2025 升级版2区）。按 OpenAlex 近年发文统计，该刊主要发表 Atrial Fibrillation Management and Outcomes、Antiplatelet Therapy and Cardiovascular Diseases、Acute Myocardial Infarction Research 等主题的论文，这 3 个主题约占 39%，主导子领域为 Cardiology and Cardiovascular Medicine。（根据 OpenAlex 主题统计与中科院分区数据生成）

We are excited to announce that as of January 2025, European Heart Journal – Cardiovascular Pharmacotherapy is now fully Open Access. By making our research freely available to all, we aim to foster collaboration, accelerate scientific progress, and ensure that groundbreaking discoveries reach a broader audience. For more information please visit the FAQ page. The European Heart Journal - Cardiovascular Pharmacotherapy (EHJ-CVP) is an official, international, peer-reviewed journal of the European Society of Cardiology (ESC) and the ESC Working Group on Cardiovascular Pharmacotherapy. The journal is dedicated to advancing clinical cardiovascular pharmacology and therapeutics. EHJ-CVP publishes original research on both novel and established drugs, including randomized clinical trials, observational, real-world and population studies, clinical research methodology, pharmacovigilance and cardiovascular drug safety, pharmacoeconomics, cardiovascular drug modelling, meta-analyses and state-of-the-art reviews. EHJ-CVP aims to advance pharmacological knowledge and improve patient care through innovation, scientific rigor, and international collaboration. While the primary focus is on clinical pharmacology, EHJ-CVP also welcomes high-quality translational research articles that contribute to the understanding and advancement of cardiovascular drug therapy. By integrating advances in pharmacodynamics, pharmacokinetics, drug metabolism, pharmacogenomics, drug–drug interactions, and early-phase development, the journal bridges bench and bedside to improve cardiovascular pharmacology. Through scientific leadership and global engagement, EHJ-CVP strives to define standards, inform guidelines, and advance personalized, evidence-based cardiovascular pharmacotherapy. Issues published per year: 8 Articles available: online only Access: open access from January 2025 Why Publish with EHJ-CVP? Discover the top 5 reasons to submit your manuscript to the Journal. Journal metrics Citation metrics Clarivate 2025 Impact Factor 8.2 2025 5 Year Impact Factor 6.1 Pharmacology & Pharmacy (Rank by Impact Factor) 20/356 Cardiac & Cardiovascular Systems (Rank by Impact Factor) 28/237 2025 Journal Citation Indicator (JCI) 1.43 Pharmacology & Pharmacy (Rank by Journal Citation Indicator) 29/356 Cardiac & Cardiovascular Systems (Rank by Journal Citation Indicator) 37/237 2025 Cited Half-Life 3.4 years 2025 Immediacy Index 3.2 2025 Eigenfactor Score 0.00504 2025 Article Influence Score 2.084

摘自期刊官网 Aims & Scope

研究方向（LetPub）：Medicine-Cardiology and Cardiovascular Medicine

主编 Bianca Rocca出版商官网

编委会国家分布：中国大陆 1 位（约 1%）；主要国家 意大利 24、美国 15、瑞典 8、法国 6、英国 5（共 105 位编委标注了国家） 编委会 ↗出版商官网 · 2026-09-30

中科院期刊分区表

数据库收录

SCIEScopusLetPub

国际期刊预警名单：各版本均未列入LetPub

不同版本、大类与小类分别展示，不将不同评价口径合并为一个分区值；投稿与考核前请确认所在机构采用的版本。

影响力指标

影响因子

8.33LetPub · 2026-09-13

影响因子（出版商公布） 2025

20出版商官网 · 2026-09-30

五年影响因子（出版商公布） 2025

6.1出版商官网 · 2026-09-30

CiteScore 2026-06

11LetPub · 2026-09-13

CiteScore（出版商公布） 2025

11出版商官网 · 2026-09-30

SJR 2026-06

2.01LetPub · 2026-09-13

SNIP 2026-06

1.38LetPub · 2026-09-13

h-index

60OpenAlex · 2026-10-01

i10-index

415OpenAlex · 2026-10-01

两年平均被引

5.01OpenAlex · 2026-10-01

自引率

15.9%LetPub · 2026-09-13

Gold OA 文章占比

49.7%LetPub · 2026-09-13

发文规模

年文章数

54LetPub · 2026-09-13

不同来源的统计口径与观测时间不同，页面保留各来源原值；“出版商公布”为期刊官网自述数据。

社区反馈来自投稿者样本，置信度 0.5，不代表期刊承诺；“出版商公布”的时间节点定义以官网为准。

混合期刊的文章处理费仅在作者选择开放获取发表时收取；按订阅方式发表通常不收费。

费用以期刊官网为准；不同来源的观测时间可能不同，页面保留各来源原值，不做平均。

出版商

Oxford University Press

出版国家或地区

United Kingdom

出版语言

English

ISSN

2055-6837

电子版 ISSN

2055-6845

官网最新一期

Volume 12, Issue 5（2026 年 8 月）

官方链接

• 期刊主页 ↗LetPub
• 投稿系统 ↗LetPub
• 专刊 / 特刊征稿 ↗出版商官网